MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP)

BMC Medical Imaging

Volumn 11, Issue , 2011, Pages

  Arbab, Ali S ^a   Shankar, Adarsh ^a   Varma, Nadimpalli R S ^a   Deeb, Dorrah ^a   Gao, Xiaohua ^a   Iskander, ASM ^a   Janic, Branislava ^a   Ali, Meser M ^a   Gautam, Subhash C ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID; BARDOXOLONE; DRUG DERIVATIVE; OLEANOLIC ACID;

ANIMAL; ARTICLE; CHEMOPROPHYLAXIS; DISEASE COURSE; MALE; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATE; PROSTATE TUMOR; SEMINAL VESICLE; TRANSGENIC MOUSE;

ANIMALS; CHEMOPREVENTION; DISEASE PROGRESSION; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, TRANSGENIC; OLEANOLIC ACID; PROSTATE; PROSTATIC NEOPLASMS; SEMINAL VESICLES;

EID: 83255164935     PISSN: None     EISSN: 14712342     Source Type: Journal    
DOI: 10.1186/1471-2342-11-21     Document Type: Article

References (26)

1. Dzubak P, Hajduch M, Vydra D, Hustova A, Kvasnica M, Biedermann D, Markova L, Urban M, Sarek J. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat Prod Rep 2006, 23(3):394-411. 10.1039/b515312n, 16741586.
2. Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber K, Ma W, Georgiadis C, Laskin JD, Conney AH. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 1994, 54(3):701-708.
3. Nishino H, Nishino A, Takayasu J, Hasegawa T, Iwashima A, Hirabayashi K, Iwata S, Shibata S. Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds. Cancer Res 1988, 48(18):5210-5215.
4. Ryu SY, Oak MH, Yoon SK, Cho DI, Yoo GS, Kim TS, Kim KM. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med 2000, 66(4):358-360. 10.1055/s-2000-8531, 10865455.
5. Yates MS, Kwak MK, Egner PA, Groopman JD, Bodreddigari S, Sutter TR, Baumgartner KJ, Roebuck BD, Liby KT, Yore MM, Honda T, Gribble GW, Sporn MB, Kensler TW. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. Cancer Res 2006, 66(4):2488-2494. 10.1158/0008-5472.CAN-05-3823, 16489057.
6. Ling X, Konopleva M, Zeng Z, Ruvolo V, Stephens LC, Schober W, McQueen T, Dietrich M, Madden TL, Andreeff M. The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. Cancer Res 2007, 67(9):4210-4218. 10.1158/0008-5472.CAN-06-3629, 17483332.
7. Liby K, Royce DB, Williams CR, Risingsong R, Yore MM, Honda T, Gribble GW, Dmitrovsky E, Sporn TA, Sporn MB. The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice. Cancer Res 2007, 67(6):2414-2419. 10.1158/0008-5472.CAN-06-4534, 17363558.
8. Sarkar SK, Mattingly MA, Kline T, Greig R. 9.4 T imaging studies of human tumor xenografts in nude mice. Invest Radiol 1988, 23(9):677-679.
9. Rodriguez O, Fricke S, Chien C, Dettin L, VanMeter J, Shapiro E, Dai HN, Casimiro M, Ileva L, Dagata J, Johnson MD, Lisanti MP, Koretsky A, Albanese C. Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Cell Cycle 2006, 5(1):113-119. 10.4161/cc.5.1.2295, 16340310.
10. Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C. In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. Prostate 2006, 66(7):708-717. 10.1002/pros.20392, 16425198.
11. Degrassi A, Russo M, Scanziani E, Giusti A, Ceruti R, Texido G, Pesenti E. Magnetic resonance imaging and histopathological characterization of prostate tumors in TRAMP mice as model for pre-clinical trials. Prostate 2007, 67(4):396-404. 10.1002/pros.20511, 17187397.
12. Nastiuk KL, Liu H, Hamamura M, Muftuler LT, Nalcioglu O, Krolewski JJ. In vivo MRI volumetric measurement of prostate regression and growth in mice. BMC Urol 2007, 7:12. 10.1186/1471-2490-7-12, 1945027, 17650332.
13. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 2001, 98(18):10350-10355. 10.1073/pnas.171326098, 56964, 11504910.
14. Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Cancer Res 2000, 60(18):5125-5133.
15. Macura KJ, Ouwerkerk R, Jacobs MA, Bluemke DA. Patterns of enhancement on breast MR images: interpretation and imaging pitfalls. Radiographics 2006, 26(6):1719-1734. quiz 1719, 10.1148/rg.266065025, 17102046.
16. Deeb D, Gao X, Liu Y, Jiang D, Divine GW, Arbab AS, Dulchavsky SA, Gautam SC. Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling. Carcinogenesis 2011, 32(5):757-764. 10.1093/carcin/bgr030, 21325633.
17. Kaplan-Lefko PJ, Chen TM, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ, Maddison LA, Foster BA, Greenberg NM. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 2003, 55(3):219-237. 10.1002/pros.10215, 12692788.
18. Gingrich JR, Barrios RJ, Foster BA, Greenberg NM. Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis 1999, 2(2):70-75. 10.1038/sj.pcan.4500296, 12496841.
19. Deeb D, Gao X, Dulchavsky SA, Gautam SC. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells. J Exp Ther Oncol 2008, 7(1):31-39.
20. Perkins S, Verschoyle RD, Hill K, Parveen I, Threadgill MD, Sharma RA, Williams ML, Steward WP, Gescher AJ. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 2002, 11(6):535-540.
21. Singh SV, Warin R, Xiao D, Powolny AA, Stan SD, Arlotti JA, Zeng Y, Hahm ER, Marynowski SW, Bommareddy A, Desai D, Amin S, Parise RA, Beumer JH, Chambers WH. Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. Cancer Res 2009, 69(5):2117-2125. 10.1158/0008-5472.CAN-08-3502, 2683380, 19223537.
22. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 2001, 61(18):6777-6782.
23. Singh SV, Powolny AA, Stan SD, Xiao D, Arlotti JA, Warin R, Hahm ER, Marynowski SW, Bommareddy A, Potter DM, Dhir R. Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice. Cancer Res 2008, 68(22):9503-9511. 10.1158/0008-5472.CAN-08-1677, 2597366, 19010926.
24. Rad AM, Gao X, Deeb D, Gautam SC, Arbab AS. Imaging Mouse Prostate Gland by 3 Tesla Clinical MRI System. Open Magn Reson Rev 2008, 1:60-63. 2583118, 19011697.
25. Ohtomo K, Itai Y, Furui S, Yashiro N, Yoshikawa K, Iio M. Hepatic tumors: differentiation by transverse relaxation time (T2) of magnetic resonance imaging. Radiology 1985, 155(2):421-423.
26. Arbab AS, Ichikawa T, Sou H, Araki T, Nakajima H, Ishigame K, Yoshikawa T, Kumagai H. Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver. Radiology 2002, 225(1):151-158. 10.1148/radiol.2251011090, 12354999.